St Jude Medical Inc (STJ)

STJ (NYSE:Health Services)
$66.80
pos +0.00
+0.00%
Today's Range: 65.32 - 66.81 | STJ Avg Daily Volume: 1,788,800
Last Update: 11/21/14 - 4:00 PM EST
Volume: 0
YTD Performance: 7.83%
Open: $0.00
Previous Close: $64.27
52 Week Range: $54.80 - $71.90
Oustanding Shares: 285,912,859
Market Cap: 18,375,619,448
6-Month Chart
TheStreet Ratings Grade for STJ
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 15 15 14 14
Moderate Buy 1 1 1 1
Hold 6 7 8 7
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
Mean Rec. 1.72 1.77 1.85 1.80
Latest Dividend: 0.27
Latest Dividend Yield: 1.68%
Dividend Ex-Date: 12/29/14
Price Earnings Ratio: 14.95
Price Earnings Comparisons:
STJ Sector Avg. S&P 500
14.95 21.20 25.70
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
3.49% 15.29% 88.01%
GROWTH 12 Mo 3 Yr CAGR
Revenue 0.00 0.07 0.02
Net Income -8.00 -0.24 -0.09
EPS 4.20 -0.09 -0.03
Earnings for STJ:
EBITDA 1.65B
Revenue 5.50B
Average Earnings Estimates
Qtr (12/14) Qtr (03/15) FY (12/14) FY (12/15)
Average Estimate $1.03 $1.00 $3.98 $4.22
Number of Analysts 13 7 16 16
High Estimate $1.04 $1.03 $3.99 $4.35
Low Estimate $1.02 $0.98 $3.97 $4.10
Prior Year $0.99 $0.96 $3.76 $3.98
Growth Rate (Year over Year) 3.81% 4.46% 5.83% 6.11%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

Bret Jensen

 | Nov 13, 2014 | 9:30 AM EST

Several big events this week will soon impact the global economy and markets.

By

Jim Cramer

 | Nov 5, 2014 | 7:09 AM EST

There are some stocks you should buy.

bearishSt. Jude numbers cut at BMO

Oct 16, 2014 | 7:57 AM EDT

Shares of STJ now seen reaching $72, according to BMO Capital. Estimates also reduced, as the company is facing currency headwinds. Outperform rating. 

By

Doug Kass

 | Oct 15, 2014 | 12:00 PM EDT
A good summary of today's earnings reports from Goldman Sachs (GS).

updateSt. Jude rated new Neutral at Sterne Agee

Jul 29, 2014 | 7:55 AM EDT

Coverage of STJ was started with a Neutral rating, Sterne Agee said. $74 price target. Uncertainty remains around the rollout of new products. 

By

Doug Kass

 | Jul 14, 2014 | 8:06 AM EDT
Where it began.
By

Jim Cramer

 | Jul 7, 2014 | 11:18 AM EDT

A wave of M&A in the health sector makes sense.

By

Gary Morrow

 | May 28, 2014 | 5:15 PM EDT

I doubt its rally stalls here

bullishSt. Jude upgraded at William Blair

Feb 10, 2014 | 7:51 AM EST

STJ was upgraded to Outperform, William Blair said. New product portfolio should drive growth in the coming quarters. 

bullishSt. Jude upgraded at Stifel

Feb 10, 2014 | 7:18 AM EST

STJ was upgraded from Hold to Buy, Stifel Nicolaus said. $75 price target. Company can show accelerating sales growth and expanding margins. 

 

REAL MONEY PRO'S BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.